News

Sirukumab is a human anti-interleukin (IL)-6 monoclonal antibody in Phase 3 development for the treatment of adults with moderately to severely active rheumatoid arthritis (RA). Janssen Research &

The ongoing trials, which were first initiated in the late last month, aim to manufacture a safer, non-prescription alternative to popular male enhancers such as Viagra, which can

The lawsuit seeks a ruling that Stemina’s services directly infringe on US patents related to global analysis of complex biological samples for the discovery of biomarkers and pathways

Agennix chief financial officer and the management board spokesperson Torsten Hombeck said Agennix objective of conserving cash has necessitated staff reductions in both Germany and the US. ”I

The project aims at developing sensitive diagnostic assay for the early detection of pancreatic ductal adenocarcinoma. With a team at University of Nebraska Medical Center, Transgenomic will test

The DMF contains factual and complete information on a drug product’s chemistry, manufacturer, stability, purity, impurity profile, packaging, and the cGMP status of any human drug product. The

Under the agreement, Pfizer will take responsibilities for the commercialization of the combined generics portfolio, managing a combined marketing and sales effort, while Mylan will manage operations including

The FDA approved generic version of 20mg, 40mg, 60mg and 80mg capsules containing Ziprasidone hydrochloride, which is used in the treatment of bipolar disorders and schizophrenia. Ziprasidone capsule

As part of the study, Millennium will evaluate the relationship between CYP genotype and clinical outcomes that include level of analgesia, functional status and clinically significant opioid-related adverse